0       0

Long Term Care Medicine-2010


B37 - Dementia Beyond Drugs: An Experiential Model for Care


Mar 12, 2010 11:00am ‐ Mar 12, 2010 12:00pm

Standard: $24.00

Description

Accreditation
The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement:
The American Medical Directors Association designates
this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

AMDCP Credit Designation:
This session has been approved for a total of 1 Management credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).

Session Description:
This session presents a re-examination of the biomedical approach to dementia that has dominated our care for the last 50 years. Antipsychotic use in dementia is an increasingly common phenomenon, despite growing evidence that the risks are high and benefits low. In order to re-engage people with life and growth, a radically different approach is needed. As an international expert in culture change, Dr. Power will reveal the shortcomings of our current approach and explain why non-pharmacologic approaches to behavioral expressions often fail. He will then use the lessons of the culture change movement to promote a paradigm shift and will craft a new 'experiential' model that allows us to re-engage people with dementia through transformation of the care environment in all of its aspects.

Learning Objectives(s):

  • Identify the shortcomings of our current approach to dementia and outline the disturbing medication trends worldwide.
  • Re-examine our studies of drug therapy for behavioral symptoms with a different perspective than medical journals have fully explored.
  • Introduce a new 'experiential' model and contrast its features with the biomedical model.
  • Explore specific applications of the new model and review personal experience and available research to date that points to its efficacy.

Speakers(s):
G. A. Power, MD

Disclosure(s):
G. A. Power, MD has no disclosures to report.

References:
Brooker, D. (2007). Person-centered dementia care: Making services better. Philadelphia: Jessica Kingsley Publishers. Kitwood, T. (1997). Dementia reconsidered: the person comes first. New York, NY: Open University Press. Cohen-Mansfield, J., & Mintzer, J. E. (2005). Time for change: the role of non-pharmacological interventions in treating behavior problems in nursing home residents with dementia. Alzheimer's Disease and Associated Disorders, 19(1), 37-40. Sabat, S. R. (2001). The experience of Alzheimer's disease: Life through a tangled veil. Malden, MA: Blackwell Publishers. Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail, M. S., et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355(15), 1525-1538. Sink, K. M., Holden, K. F., & Yaffe, K. (2005). Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. Journal of the American Medical Association, 293(5), 596-608. Taylor, R. (2007). Alzheimer's from the inside out. Baltimore: Health Professions Press. Power, G. A. (2010). Dementia beyond drugs: Changing the culture of care. Baltimore: Health Professions Press.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content